G Lercari
Overview
Explore the profile of G Lercari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruzzenenti M, Bruni R, Florio G, De Luigi M, Lercari G, Barabino G, et al.
J Clin Apher
. 2001 Apr;
16(1):37-8.
PMID: 11309832
Vascular involvement is presently considered a "common pathway" in a number of diseases that is mediated by circulating immune complexes (CIC). CIC are found in the circulation when the disease...
2.
Valbonesi M, De Luigi M, Lercari G, Florio G, Bruni R, Van Lint M, et al.
Int J Artif Organs
. 2000 Nov;
23(9):642-6.
PMID: 11059888
Since 1989 we have been collecting dry-platelets on a routine basis. Dry-platelets are those collected along with 25-30 ml of contaminating plasma cell with separators such as the Amicus, AS...
3.
Bruni R, Giannini G, Lercari G, Bo A, Florio G, De Luigi M, et al.
Transfus Sci
. 2000 Jun;
21(3):193-9.
PMID: 10848440
TTP remains enigmatic both in terms of etiology and management. The most recent approach is aggressive plasma exchange (PE) employing cryopoor plasma for replacement, based on the pathogenetic relevance given...
4.
Valbonesi M, Bruni R, Lercari G, Florio G, Carlier P, Morelli F
Transfus Sci
. 2000 Apr;
21(2):129-39.
PMID: 10747521
Transfusion of predeposit or salvaged autologous blood has continued to grow since the 1980s. Issues such as the indications for use and cost effectiveness as well as the safety of...
5.
Valbonesi M, Bruni R, Florio G, Lercari G, Cantarella S, Torretta F
Transfus Sci
. 2000 Apr;
21(2):117-21.
PMID: 10747519
In apheresis, leukodepletion by secondary filtration of the platelet components or by the primary use of special high efficiency apparatuses is widely used to meet current clinical practice. Leukodepletion of...
6.
Valbonesi M, Giannini G, Bruni R, Lercari G
Transfus Sci
. 2000 Jan;
20(1):37-42.
PMID: 10621557
No abstract available.
7.
Carella A, Lerma E, Dejana A, Corsetti M, Celesti L, Bruni R, et al.
Haematologica
. 1998 Nov;
83(10):904-9.
PMID: 9830799
Background And Objective: The main objective of this pilot study was to assess the possibility of achieving engraftment of HLA-matched sibling donor mobilized hematopoietic stem cells after immunosuppressive non-myeloablative therapy....
8.
Bacigalupo A, Mordini N, Pitto A, Piaggio G, Podesta M, Benvenuto F, et al.
Br J Haematol
. 1997 Oct;
98(3):760-6.
PMID: 9332336
This trial was designed to test the use of CD34+ selected haemopoietic stem cells (HSC) in HLA-mismatched donor-recipient pairs, following intensive conditioning with thiotepa, antilymphocyte globulin (ALG), cyclophosphamide and single-dose...
9.
Valbonesi M, Lercari G, Florio G, Carlier P, Ruzzenenti M, Bruni R, et al.
Int J Artif Organs
. 1997 May;
20(5):272-6.
PMID: 9209928
The Amicus cell separator is the latest apparatus introduced into the international market for high-yield, low WBC contamination and short-procedure time thrombocytapheresis. In its original configuration the apparatus collects platelets...
10.
Valbonesi M, Lercari G, Bruni R
Transfus Sci
. 1997 Feb;
18(1):25-6.
PMID: 10174286
No abstract available.